well, they were pretty clear on what they wanted. Arrogant CEO chose to go a different path. Hired another guy who had fallen out with FDA as their FDA ‘guru’. Not their job to stop people from being strategically dumb. The science is good, the strategy is woeful. Then advertising jobs and naming the drug that hadn’t been approved yet. More hubris. Only one person to blame here.
Ann: Update on BLA for Graft Versus Host Disease, page-229
-
- There are more pages in this discussion • 789 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |